缩短急性胆管炎抗生素疗程:开放标签随机对照试验的原理与方案
急性胆管炎标准治疗为抗菌药物联合胆道引流,但最佳疗程未知,常用7–10天,近期回顾性研究提示更短疗程可能有效。本方案拟开展多中心开放标签随机非劣效试验,比较5天短疗程(临床改善者)与至少7天长疗程,主要结局为发病30天临床治愈,估计样本量150例,非劣效界值10%。
要点
- 急性胆管炎常用抗菌疗程7–10天,回顾性研究提示更短疗程可能有效。
- 本试验比较5天短疗程(临床改善者)与至少7天长疗程,主要结局为30天临床治愈。
- 估计样本量150例,单侧α为2.5%,把握度80%,非劣效界值10%。
核心结论
- 该试验将揭示短疗程是否非劣于常规长疗程,可能为缩短急性胆管炎疗程提供证据。
研究设计与样本
- 多中心、开放标签、随机、非劣效试验,比较短疗程与常规长疗程治疗急性胆管炎。
- 短疗程组临床改善者予5天静脉抗菌治疗,长疗程组予至少7天静脉抗生素。
- 主要结局为发病30天临床治愈,随机分组为开放标签方式。
- 估计总样本量150例,单侧α为2.5%,把握度80%,非劣效界值10%。
- 试验注册号UMIN000028382,2017年8月30日注册。
关键数值与推荐
- 短疗程组:临床改善者予5天静脉抗菌治疗。
- 长疗程组:至少7天静脉抗生素。
- 主要结局:发病30天临床治愈。
- 非劣效界值10%,单侧α为2.5%,把握度80%,估计样本量150例。
临床怎么用
- 若结果支持非劣效,可考虑对临床改善的急性胆管炎患者缩短抗菌疗程,以缩短住院时间、改善生活质量、减少不良反应及抗菌药物耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial therapy with appropriate biliary drainage is considered the standard of care for acute cholangitis, but the optimal duration of antimicrobial therapy remains unknown. Seven to 10 days of antimicrobial therapy are common for the treatment of acute cholangitis, but a recent retrospective cohort study suggested a shorter duration might be effective. A shorter duration of antimicrobial therapy can be beneficial in decreasing the length of hospital stay, improving patients' quality of life, decreasing adverse effects, and even contributing to a decrease in the occurrence of antimicrobial resistance. METHODS/DESIGN: We will conduct a multi-centre, open-label, randomized, non-inferiority trial to compare short-course therapy (SCT) with conventional long-course therapy (LCT) in treating patients with acute cholangitis. SCT consists of 5-day intravenous antimicrobial therapy if the patients had clinical improvement, while at least 7 days of intravenous antibiotics will be provided to the LCT group. The primary outcome is clinical cure at 30 days after onset. Patients will be randomly assigned in an open-label fashion. A total sample size of 150 was estimated to provide a power of 80% with a one-sided α level of 2.5% and a non-inferiority margin of 10%. DISCUSSION: This trial is expected to reveal whether SCT is non-inferior to conventional LCT or not, and may provide evidence that one can shorten the treatment duration for acute cholangitis for the benefit of patients. TRIAL REGISTRATION: University Hospital Medical Information Network, UMIN000028382. Registered on 30 August 2017.
引用
- Iwata K, Doi A, Oba Y, et al. Shortening antibiotic duration in the treatment of acute cholangitis: rationale and study protocol for an open-label randomized controlled trial. Trials. 2020. PMID: 31952554. doi:10.1186/s13063-020-4046-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。